Lactate concentration in breast cancer using advanced magnetic resonance spectroscopy

Cheung, Sai Man and Husain, Ehab and Masannat, Yazan and Miller, Iain D. and Wahle, Klaus and Heys, Steven D. and He, Jiabao (2020) Lactate concentration in breast cancer using advanced magnetic resonance spectroscopy. British Journal of Cancer, 123 (2). pp. 261-267. ISSN 1532-1827

[thumbnail of Cheung-etal-BJC-2020-Lactate-concentration-in-breast-cancer-using-advanced-magnetic]
Text (Cheung-etal-BJC-2020-Lactate-concentration-in-breast-cancer-using-advanced-magnetic)
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (552kB)| Preview


    Background: Precision medicine in breast cancer demands markers sensitive to early treatment response. Aerobic glycolysis (AG) upregulates lactate dehydrogenase A (LDH-A) with elevated lactate production; however, existing approaches for lactate quantification are either invasive or impractical clinically. Methods: Thirty female patients (age 39–78 years, 15 grade II and 15 grade III) with invasive ductal carcinoma were enrolled. Lactate concentration was quantified from freshly excised whole tumours with double quantum filtered (DQF) magnetic resonance spectroscopy (MRS), and Nottingham Prognostic Index (NPI), LDH-A and proliferative marker Ki-67 were assessed histologically. Results: There was a significantly higher lactate concentration (t = 2.2224, p = 0.0349) in grade III (7.7 ± 2.9 mM) than in grade II (5.5 ± 2.4 mM). Lactate concentration was correlated with NPI (ρ = 0.3618, p = 0.0495), but not with Ki-67 (ρ = 0.3041, p = 0.1023) or tumour size (r = 0.1716, p = 0.3645). Lactate concentration was negatively correlated with LDH-A (ρ = −0.3734, p = 0.0421). Conclusion: Our results showed that lactate concentration in whole breast tumour from DQF MRS is sensitive to tumour grades and patient prognosis.